AI assistant
PFIZER INC — Director's Dealing 2021
Mar 1, 2021
29831_dirs_2021-03-01_a7071575-8eca-4b7a-b4d5-86578adb6ea3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-02-25
Reporting Person: DAMICO JENNIFER B. (SVP & Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-25 | Common Stock | M | 12477.0000 | $22.8900 | Acquired | 19781.0000 | Direct |
| 2021-02-25 | Common Stock | A | 3649.0000 | $0.0000 | Acquired | 23430.0000 | Direct |
| 2021-02-25 | Common Stock | F | 1496.0000 | $33.8200 | Disposed | 21934.0000 | Direct |
| 2021-02-25 | Common Stock | F | 8075.0000 | $34.7600 | Disposed | 13859.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-25 | Stock Appreciation Rights | $22.8900 | M | 12477.0000 | Disposed | 2021-02-25 | Common Stock (12477.0000) | Direct |
| 2021-02-25 | Stock Appreciation Rights | $33.8200 | A | 17558.0000 | Acquired | 2026-02-25 | Common Stock (17558.0000) | Direct |
| 2021-02-25 | Stock Appreciation Rights | $33.8200 | A | 15171.0000 | Acquired | 2028-02-25 | Common Stock (15171.0000) | Direct |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F6: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F7: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.